Home › advisory committee
 

Keywords :   


Tag: advisory committee

Merck Statement on FDA Advisory Committee Meeting for RAGWITEK (Short Ragweed Pollen Allergen Extract), an Investigational Sublingual Allergy Immunotherapy Tablet

2014-01-29 03:26:07| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, today said it was pleased with the positive discussion of RAGWITEK (Short Ragweed Pollen Allergen Extract) at the Allergenic Products Advisory Committee meeting of the U.S. Food and Drug Administration (FDA). Language: English read more

Tags: short statement meeting committee

 

Stakeholder Advisory Committee Meeting #2 Summary

2014-01-21 21:57:48| PortlandOnline

Notes from the SAC meeting held on December 12th, 2013 PDF Document, 197kbCategory: Stakeholder Advisory Committee

Tags: summary meeting committee advisory

 
 

Merck Statement on FDA Advisory Committee for Vorapaxar, Merck's Investigational Antiplatelet Medicine

2014-01-16 22:12:41| Biotech - Topix.net

Merck , known as MSD outside the United States and Canada, today said it was pleased with the U.S. Food and Drug Administration 's Cardiovascular and Renal Drugs Advisory Committee's recommendation for approval of vorapaxar.

Tags: statement medicine committee advisory

 

Merck Statement on FDA Advisory Committee for Vorapaxar, Mercks Investigational Antiplatelet Medicine

2014-01-16 00:59:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today said it was pleased with the U.S. Food and Drug Administration (FDA)s Cardiovascular and Renal Drugs Advisory Committees recommendation for approval of vorapaxar. Vorapaxar is the companys investigational antiplatelet medicine for the reduction of atherothrombotic events, when added to standard of care, in patients with a history of heart attack and no history of stroke or transient ischemic attack. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orPatrick Witmer, 267-305-4910orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: statement medicine committee advisory

 

OSHA to Hold Meeting of the National Advisory Committee on Occupational Safety and Health\n

2014-01-15 06:00:00| Coatings World Breaking News

Tags: national hold safety meeting

 

Sites : [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] next »